PL2495243T3 - Nowa pochodna 5-fluorouracylu - Google Patents
Nowa pochodna 5-fluorouracyluInfo
- Publication number
- PL2495243T3 PL2495243T3 PL10826686T PL10826686T PL2495243T3 PL 2495243 T3 PL2495243 T3 PL 2495243T3 PL 10826686 T PL10826686 T PL 10826686T PL 10826686 T PL10826686 T PL 10826686T PL 2495243 T3 PL2495243 T3 PL 2495243T3
- Authority
- PL
- Poland
- Prior art keywords
- novel
- fluorouracil derivative
- fluorouracil
- derivative
- Prior art date
Links
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical class FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009246400 | 2009-10-27 | ||
| EP10826686.7A EP2495243B1 (en) | 2009-10-27 | 2010-10-26 | Novel 5-fluorouracil derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2495243T3 true PL2495243T3 (pl) | 2017-07-31 |
Family
ID=43921977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10826686T PL2495243T3 (pl) | 2009-10-27 | 2010-10-26 | Nowa pochodna 5-fluorouracylu |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8889699B2 (pl) |
| EP (1) | EP2495243B1 (pl) |
| JP (1) | JP5008778B2 (pl) |
| KR (1) | KR101441770B1 (pl) |
| CN (1) | CN102574837B (pl) |
| AU (1) | AU2010312594B2 (pl) |
| DK (1) | DK2495243T3 (pl) |
| ES (1) | ES2619937T3 (pl) |
| HR (1) | HRP20170406T1 (pl) |
| HU (1) | HUE033401T2 (pl) |
| PL (1) | PL2495243T3 (pl) |
| PT (1) | PT2495243T (pl) |
| RU (1) | RU2503673C2 (pl) |
| TW (1) | TWI481604B (pl) |
| WO (1) | WO2011052554A1 (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105294575A (zh) * | 2015-12-03 | 2016-02-03 | 常州工程职业技术学院 | 一种乳清酸甲酯的制备方法 |
| CN109641004A (zh) * | 2016-07-08 | 2019-04-16 | 燕财成有限公司 | 实体癌治疗剂 |
| EP3684408A1 (en) | 2017-09-19 | 2020-07-29 | Massachusetts Institute of Technology | Compositions for chimeric antigen receptor t cell therapy and uses thereof |
| EP3856763A1 (en) | 2018-09-28 | 2021-08-04 | Massachusetts Institute of Technology | Collagen-localized immunomodulatory molecules and methods thereof |
| EP3881848B1 (en) * | 2018-11-12 | 2025-07-23 | Resonac Corporation | Method for producing orotic acid derivative |
| JP2022538974A (ja) | 2019-06-26 | 2022-09-07 | マサチューセッツ インスチテュート オブ テクノロジー | 免疫調節融合タンパク質－金属水酸化物錯体およびその方法 |
| WO2021061648A1 (en) | 2019-09-23 | 2021-04-01 | Massachusetts Institute Of Technology | Methods and compositions for stimulation of endogenous t cell responses |
| KR20220166282A (ko) | 2020-03-10 | 2022-12-16 | 매사추세츠 인스티튜트 오브 테크놀로지 | 조작된 기억-유사 nk 세포 및 이의 조성물을 생성하기 위한 방법 |
| US11896619B2 (en) | 2020-03-10 | 2024-02-13 | Massachusetts Institute Of Technology | Compositions and methods for immunotherapy of NPM1c-positive cancer |
| WO2021221782A1 (en) | 2020-05-01 | 2021-11-04 | Massachusetts Institute Of Technology | Chimeric antigen receptor-targeting ligands and uses thereof |
| CN112940152B (zh) * | 2021-01-31 | 2022-06-14 | 宁夏医科大学 | 5-氟尿嘧啶-1-甲氧羧烷基型环糊精衍生物及其制备方法 |
| TWI810543B (zh) * | 2021-03-31 | 2023-08-01 | 日商德爾塔菲製藥股份有限公司 | 使對濕度敏感之醫藥用途物質穩定化之方法及穩定製劑 |
| US11684582B2 (en) | 2021-03-31 | 2023-06-27 | Delta-Fly Pharma, Inc. | Method for stabilizing humidity-sensitive pharmaceutical substance and stabilized preparation thereof |
| WO2023081715A1 (en) | 2021-11-03 | 2023-05-11 | Viracta Therapeutics, Inc. | Combination of car t-cell therapy with btk inhibitors and methods of use thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU574155A3 (ru) * | 1973-11-28 | 1977-09-25 | Мицуи Фармасьютикалз "Инкорпорейтед" (Фирма) | Способ получени 1-ацил-5-фторурацила |
| EP0323441B1 (en) * | 1984-10-30 | 1996-04-24 | Otsuka Pharmaceutical Co., Ltd. | 5-Fluorouracil derivatives |
| JPS63301880A (ja) * | 1985-09-03 | 1988-12-08 | Otsuka Pharmaceut Co Ltd | ５−フルオロウラシル誘導体 |
| ES2058073T3 (es) * | 1986-04-30 | 1994-11-01 | Otsuka Pharma Co Ltd | Derivados de 5-fluorouracilo. |
| JPS63201127A (ja) * | 1987-02-17 | 1988-08-19 | Otsuka Pharmaceut Co Ltd | ５−フルオロウラシル誘導体を含有する制癌剤 |
| DK169520B1 (da) * | 1986-07-25 | 1994-11-21 | Otsuka Pharma Co Ltd | 5-fluoruracilderivater, fremgangsmåde til deres fremstilling, anticancerpræparat indeholdende et sådant derivat og anvendelse af et sådant derivat til fremstilling af et præparat til behandling af cancer |
| JP2706666B2 (ja) | 1987-07-31 | 1998-01-28 | 大鵬薬品工業株式会社 | ２’−デオキシ−５−フルオロウリジン誘導体及びその塩 |
| JP2700263B2 (ja) | 1988-12-16 | 1998-01-19 | 大塚製薬株式会社 | ５―フルオロウラシル誘導体の製造法 |
| US5047581A (en) * | 1989-08-25 | 1991-09-10 | Fmc Corporation | Isolation of cis-isomers from isomeric mixtures of cis/transcyclopropanecarboxylates |
| CA2087540C (en) | 1991-05-27 | 1999-01-19 | Taiho Pharmaceutical Co., Ltd. | Composition, method and kit for potentiating antitumor activity and for curing tumor |
| JPH0580451A (ja) | 1991-09-19 | 1993-04-02 | Fuji Photo Film Co Ltd | レーザー露光用ハロゲン化銀写真感光材料及びその処 理方法 |
| RU2165761C1 (ru) * | 2000-06-05 | 2001-04-27 | Уральский научно-исследовательский институт фтизиопульмонологии | Способ лечения экспериментального туберкулеза |
| WO2005074029A1 (ja) | 2004-01-28 | 2005-08-11 | Matsushita Electric Industrial Co., Ltd. | モジュール及びこれを用いた実装構造体 |
-
2010
- 2010-10-26 EP EP10826686.7A patent/EP2495243B1/en active Active
- 2010-10-26 DK DK10826686.7T patent/DK2495243T3/en active
- 2010-10-26 WO PCT/JP2010/068895 patent/WO2011052554A1/ja not_active Ceased
- 2010-10-26 HU HUE10826686A patent/HUE033401T2/en unknown
- 2010-10-26 CN CN2010800458768A patent/CN102574837B/zh active Active
- 2010-10-26 TW TW099136471A patent/TWI481604B/zh active
- 2010-10-26 PT PT108266867T patent/PT2495243T/pt unknown
- 2010-10-26 HR HRP20170406TT patent/HRP20170406T1/hr unknown
- 2010-10-26 AU AU2010312594A patent/AU2010312594B2/en active Active
- 2010-10-26 KR KR1020127013012A patent/KR101441770B1/ko active Active
- 2010-10-26 RU RU2012110380/04A patent/RU2503673C2/ru active
- 2010-10-26 ES ES10826686.7T patent/ES2619937T3/es active Active
- 2010-10-26 JP JP2011538422A patent/JP5008778B2/ja active Active
- 2010-10-26 PL PL10826686T patent/PL2495243T3/pl unknown
-
2012
- 2012-03-14 US US13/419,691 patent/US8889699B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| HK1168344A1 (en) | 2012-12-28 |
| EP2495243B1 (en) | 2016-12-28 |
| RU2012110380A (ru) | 2013-09-27 |
| TWI481604B (zh) | 2015-04-21 |
| JP5008778B2 (ja) | 2012-08-22 |
| CN102574837A (zh) | 2012-07-11 |
| US20120232103A1 (en) | 2012-09-13 |
| HUE033401T2 (en) | 2017-11-28 |
| EP2495243A4 (en) | 2015-01-14 |
| RU2503673C2 (ru) | 2014-01-10 |
| PT2495243T (pt) | 2017-03-13 |
| CN102574837B (zh) | 2013-11-27 |
| EP2495243A1 (en) | 2012-09-05 |
| WO2011052554A1 (ja) | 2011-05-05 |
| US8889699B2 (en) | 2014-11-18 |
| ES2619937T3 (es) | 2017-06-27 |
| AU2010312594A1 (en) | 2012-04-12 |
| AU2010312594B2 (en) | 2013-06-20 |
| KR101441770B1 (ko) | 2014-09-17 |
| JPWO2011052554A1 (ja) | 2013-03-21 |
| DK2495243T3 (en) | 2017-03-27 |
| HRP20170406T1 (hr) | 2017-04-21 |
| TW201121953A (en) | 2011-07-01 |
| KR20120083492A (ko) | 2012-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL220616A0 (en) | Novel 3 - hydroxy - 5 - arylisothiazole derivative | |
| EP2420493A4 (en) | HALOALKYLSULFONANILIDE DERIVATIVES | |
| EP2412708A4 (en) | SUBSTITUTED 3-HYDROXY-4-PYRIDONE DERIVATIVE | |
| EP2514747A4 (en) | SUBSTITUTED AMINOTHIAZINE DERIVATIVE | |
| PL2393812T3 (pl) | Podstawione spiroamidy jako modulatory B1R | |
| EP2495238A4 (en) | NEW 3-HYDROXY-5-ARYLISOXAZOLE DERIVATIVE | |
| IL219087A0 (en) | Benzimidazole-imidazole derivatives | |
| IL217956A0 (en) | N1-sulfonyl-5-fluoropyrimidinone derivatives | |
| GB201103481D0 (en) | No details | |
| IL213794A0 (en) | Novel uses | |
| IL217953A0 (en) | 5-fluoropyrimidinone derivatives | |
| SI2433940T1 (sl) | Spiroimidazolonski derivat | |
| GB201016096D0 (en) | No details | |
| PT2495243T (pt) | Novos derivados de 5-fluoruracilo | |
| GB201016097D0 (en) | No details | |
| PL2397480T3 (pl) | Pochodna diazepinodionu | |
| IL216007A0 (en) | Isoxazole-pyridine derivatives | |
| ZA201109437B (en) | Novel azabicyclohexanes | |
| IL215109A0 (en) | Isoxazole-pyridazine derivatives | |
| EP2456311A4 (en) | SUBSTITUTED IMIDASOTRIAZINES | |
| IL214941A0 (en) | Isoxazole-pyrazole derivatives | |
| ZA201105535B (en) | Novel tricyanoborates | |
| IL217952A0 (en) | N1-acyl-5-fluoropyrimidinone derivatives | |
| IL213927A0 (en) | Deoxyactagardine derivatives | |
| ZA201202899B (en) | 5-hydroxypyrimidine-4-carboxamide derivative |